Increasing the Survival of a Neuronal Model of Alzheimer's Disease Using Docosahexaenoic Acid, Restoring Endolysosomal Functioning by Modifying the Interactions between the Membrane Proteins C99 and Rab5

Maxime Vigier,Magalie Uriot,Fathia Djelti-Delbarba,Thomas Claudepierre,Aseel El Hajj,Frances T. Yen,Thierry Oster,Catherine Malaplate
DOI: https://doi.org/10.3390/ijms25136816
IF: 5.6
2024-06-22
International Journal of Molecular Sciences
Abstract:Docosahexaenoic acid (DHA, C22:6 ω3) may be involved in various neuroprotective mechanisms that could prevent Alzheimer's disease (AD). Its influence has still been little explored regarding the dysfunction of the endolysosomal pathway, known as an early key event in the physiopathological continuum triggering AD. This dysfunction could result from the accumulation of degradation products of the precursor protein of AD, in particular the C99 fragment, capable of interacting with endosomal proteins and thus contributing to altering this pathway from the early stages of AD. This study aims to evaluate whether neuroprotection mediated by DHA can also preserve the endolysosomal function. AD-typical endolysosomal abnormalities were recorded in differentiated human SH-SY5Y neuroblastoma cells expressing the Swedish form of human amyloid precursor protein. This altered phenotype included endosome enlargement, the reduced secretion of exosomes, and a higher level of apoptosis, which confirmed the relevance of the cellular model chosen for studying the associated deleterious mechanisms. Second, neuroprotection mediated by DHA was associated with a reduced interaction of C99 with the Rab5 GTPase, lower endosome size, restored exosome production, and reduced neuronal apoptosis. Our data reveal that DHA may influence protein localization and interactions in the neuronal membrane environment, thereby correcting the dysfunction of endocytosis and vesicular trafficking associated with AD.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the problem of endolysosomal dysfunction in Alzheimer's disease (AD), especially the impact of the interaction between the C99 fragment and Rab5 GTPase on endolysosomal function. Specifically, the study aims to evaluate whether docosahexaenoic acid (DHA) can restore endolysosomal function and improve the survival rate of neuronal models by changing the interaction between these membrane proteins. ### Specific background of the problem 1. **Pathological mechanism of Alzheimer's disease (AD)**: - AD is a neurodegenerative disease, and one of its characteristics is the dysfunction of the endolysosomal pathway. - The early dysfunction of the endolysosomal pathway may be caused by the accumulation of the C99 fragment produced by β - secretase. - The C99 fragment can interact with endosomal proteins (such as Rab5 GTPase), resulting in the enlargement of endosomes and the obstruction of maturation. 2. **Role of DHA**: - DHA (C22:6 ω3) is the most abundant ω - 3 polyunsaturated fatty acid in the brain and is considered to have multiple neuroprotective mechanisms. - However, the impact of DHA on the dysfunction of the endolysosomal pathway has not been fully explored. ### Research objectives The main objectives of this study are: - **To evaluate whether DHA can improve endolysosomal dysfunction**: Restore the normal function of endolysosomes by changing the interaction between the C99 fragment and Rab5 GTPase. - **To improve the survival rate of neuronal models**: Verify the neuroprotective effect of DHA in SH - SY5Y neuroblastoma cells expressing the Swedish mutant human amyloid precursor protein (APPswe). ### Experimental design 1. **Cell model**: - Use SH - SY5Y cells expressing APPswe as a cell model of AD. 2. **Experimental steps**: - Observe and record the phenotypic changes of endolysosomes in over - expressing APPswe cells, including the enlargement of early endosomes, the decrease in exosome secretion, and the increase in apoptosis. - Treat cells with the γ - secretase inhibitor LY to inhibit the production of Aβ peptides and observe the accumulation of the C99 fragment and its impact on endolysosomal function. - Treat cells with DHA and evaluate its impact on endolysosomal function and cell survival rate. ### Main findings - After DHA treatment, the interaction between C99 and Rab5 decreased, the size of early endosomes decreased, exosome production returned to normal, and neuronal apoptosis decreased. - These results suggest that DHA may correct the endocytic and vesicular transport dysfunctions related to AD by affecting membrane protein localization and interaction. In conclusion, this study aims to reveal the potential mechanism of DHA in improving AD - related endolysosomal dysfunction and provide a theoretical basis for the development of new treatment strategies.